ZGNX Latest News, Press Relases and Analysis

All

Press Releases

4 years ago - By: Benzinga - Mentions: IBB JAZZ BMY MRK ...

The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO

4 years ago - By: Benzinga - Mentions: SSKN HOOK RMED IBB ...

The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings

4 years ago - By: UCB, Inc.

UCB Completes Acquisition of Zogenix, Inc.

4 years ago - By: Zogenix, Inc

Zogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022

4 years ago - By: Zogenix, Inc

Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results

4 years ago - By: Investor's Business Daily - Mentions: MRNA BNTX REGN PFE ...

Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them?

4 years ago - By: WeissLaw LLP

SHAREHOLDER ALERT: WeissLaw LLP Investigates Zogenix, Inc.

4 years ago - By: Invezz

Zogenix up 60% after being acquired by UCB

4 years ago - By: Zogenix, Inc

Zogenix Supports New No-Cost Genetic Testing Program with United Mitochondrial Disease Foundation to Improve Diagnosis of Mitochondrial Diseases

4 years ago - By: Investor's Business Daily - Mentions: JAZZ

Zogenix Nabs $1.9 Billion Takeover As Epilepsy Drug Piques UCB Interest

4 years ago - By: Brodsky & Smith, LLC - Mentions: DNAC

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zogenix, Inc. (Nasdaq - ZGNX), Social Capital Suvretta Holdings Corp. III (Nasdaq - DNAC), Viveon Health Acquisition Corp. (NYSE American - VHAQ)

4 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Zogenix, Inc. has obtained a Fair Price in its transaction with UCB.

4 years ago - By: InvestorPlace - Mentions: SBEV KR DATS GENI

SBEV Stock: The Ralph’s Grocery Deal Making Waves for Splash Beverage Group Today

4 years ago - By: Halper Sadeh LLP

Zogenix (ZGNX) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Zogenix, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ZGNX

4 years ago - By: InvestorPlace - Mentions: GENI SONY

GENI Stock: The Analyst Call Sending Genius Sports Shares Surging Today

4 years ago - By: InvestorPlace - Mentions: SONY SOFI

ZOGENIX INC (ZGNX) Stock News

ZGNX Latest News, Press Relases and Analysis

The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO

The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings

UCB Completes Acquisition of Zogenix, Inc.

Zogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022

Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results

Biotech Stocks Are Down And Out; Can These 2022 Trends Save Them?

SHAREHOLDER ALERT: WeissLaw LLP Investigates Zogenix, Inc.

Zogenix up 60% after being acquired by UCB

Zogenix Supports New No-Cost Genetic Testing Program with United Mitochondrial Disease Foundation to Improve Diagnosis of Mitochondrial Diseases

Zogenix Nabs $1.9 Billion Takeover As Epilepsy Drug Piques UCB Interest

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Zogenix, Inc. (Nasdaq - ZGNX), Social Capital Suvretta Holdings Corp. III (Nasdaq - DNAC), Viveon Health Acquisition Corp. (NYSE American - VHAQ)

Shareholder Alert: Ademi LLP investigates whether Zogenix, Inc. has obtained a Fair Price in its transaction with UCB.

SBEV Stock: The Ralph’s Grocery Deal Making Waves for Splash Beverage Group Today

Zogenix (ZGNX) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Zogenix, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ZGNX

GENI Stock: The Analyst Call Sending Genius Sports Shares Surging Today

ZGNX Stock: The $1.9B UCB Deal That Has Zogenix Shares Zooming Higher Today